The TNF‐α rs1800629, IL‐10 rs1800872, and IL‐10 rs1800896 SNPs were not risk factors for AML development in our population, with similar findings being reported by Pehlivan et al.13 Similarly, a meta‐analysis of 19 publications comprising 1509 patients with leukemia and 4075 controls found no association between the TNF‐α rs1800629 polymorphism and leukemia risk.29 In contrast, a recent study showed statistically significant differences regarding the genotype and allele distribution of TNF‐α rs1800629 in CLL patients compared to controls (P = .00003 and P = .00007).30 This evidence concerns the gene IL10 and acute myeloid leukemia.